SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!
xiaoyh96
Lv4
440 积分
2024-08-30 加入
最近求助
最近应助
互助留言
Association between serum Copper-Zinc-Selenium mixture and multiple health outcomes
12小时前
待确认
Microglia replacement halts the progression of microgliopathy in mice and humans
8天前
已完结
Neuroinflammation across neurological diseases
24天前
已完结
Circulating tumor DNA Clearance as a Predictive Biomarker of Pathologic Complete Response in Patients with Solid Tumors Treated with Neoadjuvant Immune-Checkpoint Inhibitors: a Systematic Review and Meta-Analysis
1个月前
已完结
A prospective, phase II, neoadjuvant study based on chemotherapy sensitivity in HR+/HER2‐ breast cancer‐FINEST study
1个月前
已完结
ctDNA guiding adjuvant immunotherapy in urothelial carcinoma
2个月前
已完结
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
3个月前
已完结
Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort
3个月前
已完结
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
3个月前
已完结
Ultrasound-based deep learning radiomics in the assessment of pathological complete response to neoadjuvant chemotherapy in locally advanced breast cancer
3个月前
已完结
没有进行任何应助
已找到【积分已退回】
4个月前
感谢,速度真快
4个月前
点赞
4个月前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论